TWEAK/Fn14 signaling: a promising target in intervertebral disc degeneration.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Histology and Histopathology

• Publication date

  2016-02-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.14670/HH-11-775PMID 26907852
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in biological therapy for nucleus pulposus regeneration.

  2016cited by this paper
• Tumor necrosis factor-like weak inducer of apoptosis regulates the phenotype and cytotoxic activity of goat uterine natural killer cells.

  2015cited by this paper
• TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.

  2015cited by this paper
• Regulatory Tweak/Fn14 signaling pathway as a potent target for controlling bone loss.

  2015cited by this paper
• Prevalence and distribution of intervertebral disc degeneration over the entire spine in a population-based cohort: the Wakayama Spine Study.

  2014cited by this paper
• Proinflammatory Cytokine Tumor Necrosis Factor (TNF)-like Weak Inducer of Apoptosis (TWEAK) Suppresses Satellite Cell Self-renewal through Inversely Modulating Notch and NF-κB Signaling Pathways*

  2013cited by this paper
• TWEAK-Independent Fn14 Self-Association and NF-κB Activation Is Mediated by the C-Terminal Region of the Fn14 Cytoplasmic Domain

  2013cited by this paper
• Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?

  2013cited by this paper
• RG7212 Anti-TWEAK mAb Inhibits Tumor Growth through Inhibition of Tumor Cell Proliferation and Survival Signaling and by Enhancing the Host Antitumor Immune Response

  2013cited by this paper
• TWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic

  2013cited by this paper
• Safety, tolerability, pharmacokinetics, and pharmacodynamics of anti-TWEAK monoclonal antibody in patients with rheumatoid arthritis.

  2013cited by this paper
• TWEAK promotes osteoclastogenesis in rheumatoid arthritis.

  2013cited by this paper
• The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases; focus on inflammatory bowel diseases

  2012cited by this paper
• TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis.

  2012cited by this paper
• Inhibition of TNF-induced IL-6 by the TWEAK-Fn14 interaction in rheumatoid arthritis fibroblast like synoviocytes.

  2012cited by this paper
• Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.

  2012cited by this paper
• Splenic elasticity measured with real-time tissue elastography is a marker of portal hypertension.

  2011cited by this paper
• Another possible mechanism for orally administered statins retarding the pathologic process of disc degeneration.

  2011cited by this paper
• Gene expression of TWEAK/Fn14 and IP‐10/CXCR3 in glomerulus and tubulointerstitium of patients with lupus nephritis

  2011cited by this paper
• The Effects of TWEAK, Fn14, and TGF-beta1 on Degeneration of Human Intervertebral Disc.

  2010cited by this paper
• Aging of the Cervical Spine in Healthy Volunteers: A 10-Year Longitudinal Magnetic Resonance Imaging Study

  2009cited by this paper
• TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells.

  2009cited by this paper
• Mechanism of Signal Transduction in Tumor Necrosis Factor-Like Weak Inducer of Apoptosis-Induced Matrix Degradation by MMP-3 Upregulation in Disc Tissues

  2008cited by this paper
• Novel function of TWEAK in inducing intervertebral disc degeneration

  2007cited by this paper
• The aging spine: the role of inflammatory mediators in intervertebral disc degeneration.

  2007cited by this paper
• Back surgery--who needs it?

  2007cited by this paper
• TWEAK Is a Novel Arthritogenic Mediator

  2006cited by this paper
• Involvement of TNF-Like Weak Inducer of Apoptosis in the Pathogenesis of Collagen-Induced Arthritis1

  2006cited by this paper
• The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.

  2004cited by this paper
• TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.

  2003cited by this paper
• TWEAK Mediates Signal Transduction and Differentiation of RAW264.7 Cells in the Absence of Fn14/TweakR

  2003cited by this paper
• Classification of Age-Related Changes in Lumbar Intervertebral Discs: 2002 Volvo Award in Basic Science

  2002cited by this paper
• Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies

  2001cited by this paper
• The relationship between cartilage end-plate calcification and disc degeneration: an experimental study.

  2001cited by this paper
• Down-regulated expression of TWEAK mRNA in acute and chronic inflammatory pathologies.

  2000cited by this paper
• Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption.

  2000cited by this paper
• TWEAK Induces Angiogenesis and Proliferation of Endothelial Cells*

  1999cited by this paper
• TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis*

  1997cited by this paper
• The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration.

  1996cited by this paper

• Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-?B pathway in the pathogenesis of cancer

  2021cites this paper
• TWEAK and TSLP in disc degeneration and spontaneous hernia resorption

  2020cites this paper
• Quantitative Multiplex Immunoassay for Profiling Bone Turnover Biomarkers in Human Bone Tissue Culture Supernatants.

  2018cites this paper